RNA Extraction Kit Components (Silica Columns, Chaotropic Salts)

QIAGEN NV (Venlo, Netherlands; operational HQ Hilden, Germany); market leader in DNA/RNA extraction kits with 22-26% global share; flagship QIAamp Viral RNA Mini Kit is the WHO-recommended standard for respiratory virus testing including SARS-CoV-2; manufacturing in Hilden (Germany), Barcelona (Spain), Germantown MD (USA), and Suzhou (China); in March 2020 Qiagen operated 3 shifts/7 days to meet COVID demand at Hilden and Barcelona; Thermo Fisher attempted $11.5B acquisition in 2020 but withdrew in August 2020; Qiagen remains independent with a partial stake held by Danaher

Thermo Fisher Scientific (Waltham MA; NYSE: TMO; ~$43B revenue 2024) is the world's largest manufacturer of cell culture media through its Gibco brand — the dominant label in CHO (Chinese Hamster Ovary) cell culture media for biopharmaceutical manufacturing. Gibco CHO-S Serum-Free Medium, GlutaMAX supplement, CD CHO medium, and EX-CELL Advanced CHO media series supply the majority of global monoclonal antibody manufacturing processes. Thermo Fisher's cell culture media is manufactured primarily at its Grand Island, NY facility (acquired from Life Technologies, itself formerly GIBCO BRL), which is the single most important cell culture media manufacturing site in North America. Thermo Fisher also operates a major media production site in Paisley, Scotland (UK) that serves European biopharmaceutical manufacturing. Gibco media formulations are validated into more FDA-approved biologics manufacturing processes than any other supplier — creating regulatory lock-in equivalent to Cytiva's position in chromatography resins. The 2014 Thermo Fisher merger with Life Technologies (which itself had acquired Invitrogen in 2008 and GIBCO BRL in 2000) consolidated what were once multiple competing cell culture brands into a single dominant supplier.

Diagnostic division of F. Hoffmann-La Roche (Basel, Switzerland); manufactures viral RNA extraction kits including the High Pure Viral RNA Kit and MagNA Pure series; integrated with Roche cobas PCR system for automated end-to-end COVID testing; ~10-12% of RNA extraction kit market; manufacturing in Mannheim, Germany (primary) and Penzberg, Bavaria; FDA approved the Roche extraction kit as an alternative to Qiagen during COVID, but Roche was also on backorder simultaneously

Life science research and diagnostics company (NYSE: BIO); Hercules, California; manufactures RNA purification kits and real-time PCR reagents; known for ddPCR (digital droplet PCR) technology; 5-8% of DNA/RNA extraction market; important supplier for research and smaller diagnostic labs; does not have Qiagen's scale in clinical viral RNA extraction